Literature DB >> 23208425

Obsessive-compulsive disorders.

Per Hove Thomsen1.   

Abstract

Three major changes will probably be introduced in the DSM-5 regarding obsessive-compulsive disorder: OCD will be classified in the diagnostic category 'obsessive-compulsive and related disorders', the clinician should consider the degree of insight into a symptomatology (good to poor insight) and a subtype of tic-related OCD will be introduced. The recommended treatment for OCD is CBT, in severe cases with addition of SSRI treatment.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23208425     DOI： 10.1007/s00787-012-0357-7

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


  12 in total

1.  Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Authors:  Rukiye Çolak Sivri; Ayhan Bilgiç; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-01-04       Impact factor: 4.785

Review 2.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

3.  Child and adolescent psychiatry in ICD-11: an opportunity to overcome mistakes made in DSM-5?

Authors:  Veit Roessner; Stefan Ehrlich; Nora C Vetter
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09       Impact factor: 4.785

4.  Assessing Acute Secondary Treatment Outcomes in Early-Onset Obsessive-Compulsive Disorder.

Authors:  Mary Kathryn Cancilliere; Jennifer Freeman; Abbe Garcia; Kristen Benito; Jeffrey Sapyta; Martin Franklin
Journal:  Child Psychiatry Hum Dev       Date:  2018-10

5.  Impact of Gender, Age at Onset, and Lifetime Tic Disorders on the Clinical Presentation and Comorbidity Pattern of Obsessive-Compulsive Disorder in Children and Adolescents.

Authors:  Canan Tanidir; Hilal Adaletli; Hatice Gunes; Ali Guven Kilicoglu; Caner Mutlu; Mustafa Kayhan Bahali; Tugce Aytemiz; Ozden Sukran Uneri
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-06       Impact factor: 2.576

6.  Obsessive-compulsive symptoms in children and adolescents: symptomatology, impairment and quality of life.

Authors:  Elien De Caluwé; Barbara De Clercq
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-02-12       Impact factor: 4.785

7.  Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial.

Authors:  Sophia Esalatmanesh; Mojtaba Biuseh; Ahmad Ali Noorbala; Seyed-Ali Mostafavi; Farzin Rezaei; Bita Mesgarpour; Payam Mohammadinejad; Shahin Akhondzadeh
Journal:  Iran J Psychiatry       Date:  2017-07

8.  Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.

Authors:  Sanaz Askari; Saba Mokhtari; Seyed Vahid Shariat; Behnam Shariati; Masoomeh Yarahmadi; Mohammadreza Shalbafan
Journal:  BMC Psychiatry       Date:  2022-01-12       Impact factor: 3.630

9.  Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication‑free children.

Authors:  Ayhan Bilgiç; Merve Sertdemir; İbrahim Kılınç; Ömer Faruk Akça
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

Review 10.  The neurobiological link between OCD and ADHD.

Authors:  Silvia Brem; Edna Grünblatt; Renate Drechsler; Peter Riederer; Susanne Walitza
Journal:  Atten Defic Hyperact Disord       Date:  2014-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.